Literature DB >> 17972590

[Effect of resveratrol on heart function of rats with adriamycin-induced heart failure].

Gui-ying Wang1, Yong-mei Wang, Li-nan Zhang, Qian Li, Hua Yue, Cui-miao Song, Jing-kun Feng, Na Wang.   

Abstract

OBJECTIVE: To observe the protective effects of resveratrol (RES) on the heart function of the rats with adriamycin-induced heart failure.
METHOD: Thirty adult male SD rats were randomly divided into 5 groups: normal control (NC) group, adriamycin (ADR) group, RESL + ADR group, RES(H) + ADR group and RES group. RES of 30, 120, 120 mg x kg(-1) x d(-1) was given intraperitoneally (ip) once a day for 3 days in RES(L) + ADR group, RES(H) + ADR group and RES group respectively. The other two groups were given the same amount of normal saline the same way. On the 4h day,ADR of 10 mg x kg(-1) was given intraperitoneally once to induce myocardium injury model. After twenty-four hours, the pathological and biochemical changes of the myocardium were examined. RESULT: As compared with NC group, the MDA, NO and NOS of the ADR group were significantly higher (P < 0.05), and the SOD of the ADR group were markedly lower (P < 0.05). As compared with ADR group, the indexes in RES(L) + ADR group, RES(H) + ADR group were exactly opposing, and took on dose dependance (P < 0.05). Light microscopic morphometry of the heart samples of the rats in ADR + RES(L, H) groups revealed typical diminishing of damage.
CONCLUSION: RES can relieve the toxic effects of ADR on myocardium, and the cardioprotective effects may be correlated with its antioxidant activity and downregulation of NO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17972590

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  7 in total

1.  Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.

Authors:  Manar Hamed Arafa; Nanies Sameeh Mohammad; Hebatallah Husseini Atteia; Hesham Radwan Abd-Elaziz
Journal:  J Physiol Biochem       Date:  2014-06-18       Impact factor: 4.158

2.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

3.  Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity.

Authors:  Jaroslaw Dudka; Renata Gieroba; Agnieszka Korga; Franciszek Burdan; Wlodzimierz Matysiak; Barbara Jodlowska-Jedrych; Slawomir Mandziuk; Elzbieta Korobowicz; Marek Murias
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-26       Impact factor: 2.629

Review 4.  Integrative Therapies and Cardiovascular Disease in the Breast Cancer Population: A Review, Part 1.

Authors:  Khara Lucius; Kristen Trukova
Journal:  Integr Med (Encinitas)       Date:  2015-08

Review 5.  Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity.

Authors:  Shreesh Ojha; Hasan Al Taee; Sameer Goyal; Umesh B Mahajan; Chandrgouda R Patil; D S Arya; Mohanraj Rajesh
Journal:  Oxid Med Cell Longev       Date:  2016-05-23       Impact factor: 6.543

Review 6.  Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art.

Authors:  Beniamino Pagliaro; Caterina Santolamazza; Francesca Simonelli; Speranza Rubattu
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

Review 7.  A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases.

Authors:  Albino Carrizzo; Carmine Izzo; Maurizio Forte; Eduardo Sommella; Paola Di Pietro; Eleonora Venturini; Michele Ciccarelli; Gennaro Galasso; Speranza Rubattu; Petro Campiglia; Sebastiano Sciarretta; Giacomo Frati; Carmine Vecchione
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.